Add Formweb to your mobile device
Approved Formulary
Search results for:
tofacitinib
tofacitinib
- Restricted Medications Non-Formulary / Not-stocked
Brand names: Xeljanz
No brands, forms, or strengths have been added for this generic.
Medication comments:
| Per policy, these hazardous drugs have special waste requirements. | |
|---|---|
| Generic (Brand) | Waste Requirements |
| tofacitinib (Xeljanz) | Hazardous Waste ⇒ BLACK BUCKET |
| USP <800> Hazardous Drugs | ||||||
|---|---|---|---|---|---|---|
| Per Policy, these drugs have special handling requirements (any drug with an "AOR" is exempt from these requirements under normal circumstances). | ||||||
| generic (Brand) Route | Relative Risk Level | AOR? | NIOSH 2024 Table | MSHI?↑ | Warnings | |
| tofacitinib (Xeljanz) PO | Medium | N/A | 2↑ | |||
| NIOSH Supplemental information (2016): Black Box warning for lymphoma and other malignancies FDA Pregancy Category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks; | ||||||
Last updated: Jun. 5, 2025
- Hazard.Drug Handling(USP 800) USP<800> Hazardous Drug
- Hazardous Waste BLACK BUCKET
- Black Box Warnings Serious Infections, Mortality, Malignancy, Major Adverse Cardiovascular Events (MACE), and Thrombosis